Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

RTTNews | 660 gün önce
Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

(RTTNews) - Pharmaceutical companies Astellas Pharma Inc. (ALPMY.PK) and Poseida Therapeutics, Inc. (PSTX) announced Monday a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy.

Under the terms of the transaction agreements, Astellas will invest a total of $50 million, including $25 million to acquire 8.3 million shares of common stock of Poseida or approximately 8.8% of the outstanding common stock of Poseida, at $3.00 per share in a private placement.

It will also make a one-time $25 million payment for a right of exclusive negotiation and first refusal to license one of Poseida's clinical stage programs: P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy in development for multiple solid tumor indications.

In addition, Poseida has granted Astellas a board observer seat, which includes the ability to attend Poseida's scientific advisory board meetings, and certain notice rights related to any potential change of control of Poseida.

read more
Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Astellas Pharma Inc. announced Friday the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of XTANDI (enzalutamide) as monotherapy or in combination with androgen deprivation therapy for the treatment of adult men with high risk biochemical recurrent (BCR) non-metastatic hormone sensitive prostate cancer (nmHSPC) who are unsuitable for salvage radiotherapy.
RTTNews | 432 gün önce
CAC 40 Down Marginally In Lackluster Trade

CAC 40 Down Marginally In Lackluster Trade

French stocks are moving in a tight range in cautious trade on Wednesday as investors digest a slew of domestic economic reports, and continue to assess the impact of Trump administration's trade policy on global economic growth.
RTTNews | 39 dakika önce
DAX Modestly Lower In Cautious Trade

DAX Modestly Lower In Cautious Trade

German stocks are modestly lower on Wednesday with investors mostly making cautious moves, looking for directional clues after recent gains on the back of U.S. President Donald Trump's decision to pause tariffs on EU goods till July 9th.
RTTNews | 1s 6 dakika önce
France GDP Growth Confirmed At 0.1%

France GDP Growth Confirmed At 0.1%

The French economy recovered in the first quarter, as initially estimated, the statistical office INSEE reported Wednesday. Gross domestic product grew 0.1 percent from the fourth quarter, when the economy shrank 0.1 percent.
RTTNews | 1s 48 dakika önce